200 related articles for article (PubMed ID: 22374749)
21. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.
Mazar J; Khaitan D; DeBlasio D; Zhong C; Govindarajan SS; Kopanathi S; Zhang S; Ray A; Perera RJ
PLoS One; 2011; 6(9):e24922. PubMed ID: 21949788
[TBL] [Abstract][Full Text] [Related]
23. Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma.
Huynh KT; Takei Y; Kuo C; Scolyer RA; Murali R; Chong K; Takeshima L; Sim MS; Morton DL; Turner RR; Thompson JF; Hoon DS
Br J Dermatol; 2012 Jun; 166(6):1319-26. PubMed ID: 22293026
[TBL] [Abstract][Full Text] [Related]
24. A microRNA DNA methylation signature for human cancer metastasis.
Lujambio A; Calin GA; Villanueva A; Ropero S; Sánchez-Céspedes M; Blanco D; Montuenga LM; Rossi S; Nicoloso MS; Faller WJ; Gallagher WM; Eccles SA; Croce CM; Esteller M
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13556-61. PubMed ID: 18768788
[TBL] [Abstract][Full Text] [Related]
25. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
26. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
[TBL] [Abstract][Full Text] [Related]
27. CpG island methylation profiling in human melanoma cell lines.
Tellez CS; Shen L; Estécio MR; Jelinek J; Gershenwald JE; Issa JP
Melanoma Res; 2009 Jun; 19(3):146-55. PubMed ID: 19441164
[TBL] [Abstract][Full Text] [Related]
28. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer.
Cui H; Hu Y; Guo D; Zhang A; Gu Y; Zhang S; Zhao C; Gong P; Shen X; Li Y; Wu H; Wang L; Zhao Z; Fan H
Oncogene; 2018 Aug; 37(32):4358-4371. PubMed ID: 29717263
[TBL] [Abstract][Full Text] [Related]
29. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
Hoon DS; Spugnardi M; Kuo C; Huang SK; Morton DL; Taback B
Oncogene; 2004 May; 23(22):4014-22. PubMed ID: 15064737
[TBL] [Abstract][Full Text] [Related]
30. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
31. Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin.
Li N; Liu Y; Pang H; Lee D; Zhou Y; Xiao Z
Med Sci Monit; 2019 Mar; 25():1590-1599. PubMed ID: 30821276
[TBL] [Abstract][Full Text] [Related]
32. Epigenetics of regional lymph node metastasis in solid tumors.
Huynh KT; Hoon DS
Clin Exp Metastasis; 2012 Oct; 29(7):747-56. PubMed ID: 22684433
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
[TBL] [Abstract][Full Text] [Related]
34. Genetic and epigenetic alterations in sentinel lymph nodes metastatic lesions compared to their corresponding primary breast tumors.
Cavalli LR; Urban CA; Dai D; de Assis S; Tavares DC; Rone JD; Bleggi-Torres LF; Lima RS; Cavalli IJ; Issa JP; Haddad BR
Cancer Genet Cytogenet; 2003 Oct; 146(1):33-40. PubMed ID: 14499694
[TBL] [Abstract][Full Text] [Related]
35. CpG island methylator phenotype predicts progression of malignant melanoma.
Tanemura A; Terando AM; Sim MS; van Hoesel AQ; de Maat MF; Morton DL; Hoon DS
Clin Cancer Res; 2009 Mar; 15(5):1801-7. PubMed ID: 19223509
[TBL] [Abstract][Full Text] [Related]
36. DNA hypermethylation is associated with invasive phenotype of malignant melanoma.
Koroknai V; Szász I; Hernandez-Vargas H; Fernandez-Jimenez N; Cuenin C; Herceg Z; Vízkeleti L; Ádány R; Ecsedi S; Balázs M
Exp Dermatol; 2020 Jan; 29(1):39-50. PubMed ID: 31602702
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.
Metge BJ; Frost AR; King JA; Dyess DL; Welch DR; Samant RS; Shevde LA
Clin Exp Metastasis; 2008; 25(7):753-63. PubMed ID: 18566899
[TBL] [Abstract][Full Text] [Related]
38. Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions.
Rivenbark AG; Livasy CA; Boyd CE; Keppler D; Coleman WB
Exp Mol Pathol; 2007 Oct; 83(2):188-97. PubMed ID: 17540367
[TBL] [Abstract][Full Text] [Related]
39. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
[TBL] [Abstract][Full Text] [Related]
40. Gene promoter hypermethylation in mouse lung tumors.
Vuillemenot BR; Hutt JA; Belinsky SA
Mol Cancer Res; 2006 Apr; 4(4):267-73. PubMed ID: 16603640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]